tolvaptan has been researched along with Hypovolemia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K | 1 |
Deitelzweig, SB; McCormick, L | 1 |
Castillo, JJ; Justice, E; Vincent, M | 1 |
Dabrowska, MD; Krysiak, R; Okopień, B | 1 |
Hatano, M; Imamura, T; Inaba, T; Kato, N; Kinugawa, K; Kyo, S; Maki, H; Minatsuki, S; Muraoka, H; Nagai, R; Shiga, T; Yao, A | 1 |
Hoorn, EJ; Zietse, R | 1 |
4 review(s) available for tolvaptan and Hypovolemia
Article | Year |
---|---|
Management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome | 2014 |
Hyponatremia in hospitalized patients: the potential role of tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diagnosis, Differential; Hospitalization; Humans; Hyponatremia; Hypovolemia; Quality Indicators, Health Care; Severity of Illness Index; Time Factors; Tolvaptan | 2011 |
Diagnosis and management of hyponatremia in cancer patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Management; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Neoplasms; Receptors, Vasopressin; Risk Factors; Sodium; Tolvaptan | 2012 |
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan | 2012 |
1 trial(s) available for tolvaptan and Hypovolemia
Article | Year |
---|---|
Novel criteria of urine osmolality effectively predict response to tolvaptan in decompensated heart failure patients--association between non-responders and chronic kidney disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Urea Nitrogen; Creatine; Diabetes Insipidus, Nephrogenic; Diuretics; Drug Monitoring; Female; Heart Failure; Humans; Hypovolemia; Logistic Models; Male; Middle Aged; Osmolar Concentration; Potassium; Predictive Value of Tests; Renal Insufficiency, Chronic; Sensitivity and Specificity; Sodium; Tolvaptan; Ultrasonography; Urine; Young Adult | 2013 |
1 other study(ies) available for tolvaptan and Hypovolemia
Article | Year |
---|---|
Tolvaptan for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Tolvaptan | 2007 |